RPS29P26

Across TCGA pan-cancer cohorts, RPS29P26 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RPS29P26 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RPS29P26 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS29P26 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

OV, MESO, and UCEC are the cancer types where RPS29P26 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	III,IV	0.211	0.537	<.001	114	view →
MESO	OS	Tertile	III,IV	0.069	0.580	<.001	108	view →
UCEC	OS	Tertile	II,III,IV	0.201	0.771	.002	72	view →
STAD	OS	Tertile	All	0.379	0.747	<.001	54	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
READ	OS	Tertile	II,III,IV	0.083	0.919	<.001	36	view →
UVM	OS	Tertile	All	0.292	0.674	.035	18	view →
LGG	OS	Tertile	All	0.415	0.811	.041	9	view →
SKCM	OS	Tertile	All	0.210	0.781	<.001	9	view →
ESCA	DFS	Tertile	All	0.771	0.481	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RPS29P26–OV (DFS)

Open the OV breakdown →